Dr. Blevins on GLP Medications: Listener Questions and Insights (Part 2)

GLP-1 Medications for Children

• ⚠️ GLP-1 medications are not currently approved for children under 12 for weight loss or diabetes management, with Saxenda (liraglutide) being the only exception for weight loss in those 12 and older.
• 🩺 Doctors may prescribe medications off-label, but there is limited data on safety and efficacy for very young children like a seven-year-old.
• 💡 A dietitian might be a helpful resource for addressing eating habits and weight concerns in children.

Muscle Loss and GLP-1s

• 🏋️ While some initially expressed concern about muscle loss with GLP-1s, studies show that with regular activity and resistance exercise, significant muscle loss is unlikely.
• 📉 Fat loss, particularly visceral fat, is the primary outcome, and maintaining muscle mass is achievable through activity.
• 💪 Protein intake, such as from beef and chicken, is also recommended to support muscle health.

Pancreatitis Concerns and GLP-1s

• 🩸 Elevated lipase and amylase levels can occur with GLP-1 use, but without accompanying pain, it's unclear if this indicates impending pancreatitis.
• ❓ There is no clear evidence that GLP-1 medications directly cause pancreatitis, but they do affect the pancreas.
• 🩺 Decisions about continuing medication in such cases are clinical judgment calls between the patient and doctor.

Medication Absorption and GLP-1s

• 💊 GLP-1 medications can affect the absorption of oral medications by slowing gastric emptying.
• ⏳ This effect is most pronounced early in treatment and with dose increases, but may gradually improve over time.
• ⚖️ Managing this can involve adjusting GLP-1 doses, timing, or exploring alternative medications, often requiring a trial-and-error approach.

Gastrointestinal Side Effects and Diet

• 🤢 GLP-1s can cause nausea and vomiting, especially when combined with a high-fat diet, as fat also slows gastric emptying.
• 🥗 Reducing fat intake and focusing on lean proteins and vegetables can help mitigate these side effects.
• 🍽️ Low-carb diets do not necessarily need to be high-fat; a focus on complex carbohydrates like vegetables is key.

Cancer Risks and GLP-1s

• ⚠️ The boxed warning for medullary thyroid cancer is based on rodent studies, and while rare, individuals with a personal or family history of this specific cancer or MEN2 should avoid GLP-1s.
• 📈 There is no evidence that GLP-1s cause common types of thyroid cancer or pancreatic cancer.
• 🤝 Open communication with an endocrinologist is crucial to discuss individual risks and benefits.

Risk-Benefit Analysis and Side Effects

• ✅ The decision to use GLP-1s involves a benefit-risk analysis, weighing potential advantages against possible side effects.
• 📉 While some individuals experience significant GI symptoms (nausea, vomiting, diarrhea, constipation) leading to discontinuation (4-8% in studies), many tolerate them well, especially with dose adjustments and lifestyle modifications like lower fat intake.
• 🗣️ Patient experiences vary widely, and what might be a deal-breaker for one person may be a manageable side effect for another.

GLP-1s and Insulin Needs in Type 1 Diabetes

• 📉 GLP-1s can potentially reduce insulin needs in type 1 diabetes by slowing gastric emptying, delaying glucose absorption, reducing appetite, and improving insulin sensitivity through weight loss.
• 🔬 While not FDA-approved for type 1 diabetes, research is ongoing, and medications like tirzepatide (Mounjaro, Zepbound) show promise due to their effects on appetite, gastric emptying, and insulin sensitivity.

Gastric Emptying and Reflux

• 💨 GLP-1s slow gastric emptying, which can sometimes worsen reflux, but weight loss itself can reduce pressure on the stomach and alleviate reflux symptoms.
• ⚖️ Eating smaller volumes and reducing visceral fat can also contribute to less pressure and reduced reflux.

GLP-1s in Patients with Gastric Surgery History

• 🤔 For individuals with significant intestinal removal or gastric bypass, the use of GLP-1s is unclear and requires careful consideration with a doctor, as it could theoretically impact digestion further.
• ⚠️ Established gastroparesis is generally a contraindication for GLP-1 use.

Metformin vs. GLP-1s

• 📉 Metformin primarily reduces liver glucose output and has limited and inconsistent effects on weight loss and insulin resistance in type 1 diabetes compared to GLP-1s.
• 🚀 GLP-1s show more significant benefits in weight loss and cardiovascular/kidney health outcomes, though they are not approved for type 1 diabetes.

Long-Term Use and Supply Issues

• ⏳ While long-term safety data is still accumulating, millions of users have not shown new adverse signals, suggesting general safety for long-term use.
• 🔄 Maintaining the medication is generally required to sustain benefits, though dose or frequency adjustments may be possible.
• ⚠️ Supply shortages can lead to dose fluctuations, causing annoyance and requiring adjustments, but are not typically considered harmful in the long run.

GLP-1s and Other Conditions

• 📊 GLP-1s have no known effect on Hashimoto's thyroiditis and may improve cholesterol levels, likely due to weight loss.
• 🧪 Research is exploring GLP-1s for various conditions, including arthritis, sleep apnea, and cognitive function, but more data is needed.

Micro-dosing GLP-1s

• 🔬 The concept of micro-dosing GLP-1s for autoimmune diseases or non-weight loss benefits is interesting but lacks supporting data and requires rigorous study.
• 🤔 While lower doses might reduce side effects, they may also eliminate efficacy.

Societal Perception of Weight Loss

• 👀 Society's accustomedness to larger body masses can lead to shock or concern when individuals achieve healthy weights on GLP-1s, with some being told they look